Education
About Us
Working with TipRanks
Follow Us
Ribomic, Inc. (JP:4591)
:4591
4591 Stock Chart & Stats
¥89.00
¥23.00(27.71%)
At close: 4:00 PM EST
¥89.00
¥23.00(27.71%)
Day’s Range― - ―
52-Week Range¥74.00 - ¥141.00
Previous CloseN/A
Volume38.87M
Average Volume (3M)528.99K
Market Cap
¥4.28B
Enterprise Value¥1.25B
Total Cash (Recent Filing)¥2.81B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.09
Shares Outstanding51,613,940
10 Day Avg. Volume560,080
30 Day Avg. Volume528,993
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)1.30
Price to Sales (P/S)1880.02
P/FCF Ratio-3.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ribomic, Inc. News
4591 FAQ
What was Ribomic, Inc.’s price range in the past 12 months?
Ribomic, Inc. lowest stock price was ¥74.00 and its highest was ¥141.00 in the past 12 months.
What is Ribomic, Inc.’s market cap?
Ribomic, Inc.’s market cap is ¥4.28B.
When is Ribomic, Inc.’s upcoming earnings report date?
Ribomic, Inc.’s upcoming earnings report date is Feb 06, 2026 which is in 70 days.
How were Ribomic, Inc.’s earnings last quarter?
Ribomic, Inc. released its earnings results on Nov 12, 2025. The company reported -¥6.09 earnings per share for the quarter, missing the consensus estimate of N/A by -¥6.09.
Is Ribomic, Inc. overvalued?
According to Wall Street analysts Ribomic, Inc.’s price is currently Overvalued.
Does Ribomic, Inc. pay dividends?
Ribomic, Inc. does not currently pay dividends.
What is Ribomic, Inc.’s EPS estimate?
Ribomic, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ribomic, Inc. have?
Ribomic, Inc. has 51,613,940 shares outstanding.
What happened to Ribomic, Inc.’s price movement after its last earnings report?
Ribomic, Inc. reported an EPS of -¥6.09 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.409%.
Which hedge fund is a major shareholder of Ribomic, Inc.?
Currently, no hedge funds are holding shares in JP:4591
Company Description
Ribomic, Inc.
Ribomic, Inc. (4591) is a biotechnology company specializing in the development of aptamer-based therapeutics. Aptamers are short, single-stranded DNA or RNA molecules that can bind to specific targets, such as proteins, with high affinity and specificity. Ribomic focuses on creating innovative treatments for a variety of diseases, including ocular disorders, through its proprietary RiboART platform. The company operates within the pharmaceutical and biotechnology sectors, advancing its pipeline of products towards clinical trials and potential commercialization.
Technical Analysis
Immuno-Biological Laboratories Co., Ltd.
―
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
BrightPath Biotherapeutics Co.Ltd.
―
FunPep Company Limited
―